David Protein
Coverage of David Protein in the Nexus archive.
- David Protein CEO says ‘diet trends are over’ because of GLP-1s: ‘What’s next is really hard to predict’
David Protein CEO Peter Rahal claims GLP-1 receptor agonists are ending traditional diet trends, citing their impact on appetite regulation and weight loss. Food companies like Nestle and Conagra are adapting by creating products for GLP-1 users, while David Protein capitalizes on 'proteinmaxxing' to meet demand for high-protein snacks. The rise of GLP-1 medications has disrupted weight loss programs, contributing to WeightWatchers' bankruptcy and a shift in food industry priorities.
- Your ‘proteinmaxxing’ is creating a whey shortage that’s ratcheting up prices and leaving snack companies to eat costs or make recipes worse
Whey protein prices have nearly doubled due to increased demand for high-protein foods, driven by GLP-1 weight loss drugs and revised dietary guidelines. Companies face supply shortages and must choose between absorbing costs or compromising product quality, as switching to alternative proteins proves challenging due to taste and texture issues.